Gandewar Brothers Drugs & Chemicals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 03-12-2024
- Paid Up Capital ₹ 0.10 M
as on 03-12-2024
- Company Age 6 Year, 1 Month
About Gandewar Brothers Drugs & Chemicals
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Santhosh Gandewar and Shilpa Gandewar serve as directors at the Company.
- CIN/LLPIN
U24304MH2018PTC316533
- Company No.
316533
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Oct 2018
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nagpur, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Gandewar Brothers Drugs & Chemicals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Santhosh Gandewar  | Director | 30-Oct-2018 | Current |
| Shilpa Gandewar | Director | 30-Oct-2018 | Current |
Financial Performance of Gandewar Brothers Drugs & Chemicals.
Enhance accessibility to Gandewar Brothers Drugs & Chemicals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Gandewar Brothers Drugs & Chemicals?
Unlock access to Gandewar Brothers Drugs & Chemicals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
G.B Farms & Resorts LlpActive 7 years 11 monthsSanthosh Gandewar and Shilpa Gandewar are mutual person
- Bhagyawathi Yarns Private LimitedActive 4 years 6 months
Santhosh Gandewar and Shilpa Gandewar are mutual person
- Bhagyawathi Drugs & Chemicals Private LimitedActive 2 years 1 month
Santhosh Gandewar and Shilpa Gandewar are mutual person
- Gandewar Brothers Pharmaceuticals Private LimitedActive 6 years 1 month
Santhosh Gandewar and Shilpa Gandewar are mutual person
- Gandewar Brothers Infraventures Private LimitedActive 6 years 1 month
Santhosh Gandewar and Shilpa Gandewar are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Gandewar Brothers Drugs & Chemicals?
Unlock and access historical data on people associated with Gandewar Brothers Drugs & Chemicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gandewar Brothers Drugs & Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gandewar Brothers Drugs & Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
